Doximity (DOCS, Financial) reported impressive fourth-quarter revenue figures, reaching $138.3 million, surpassing the consensus estimate of $134 million. The company concluded fiscal year 2025 with notable achievements including a 20% increase in annual revenue. This growth was driven by record-high engagement and strong profitability. Key areas such as the newsfeed, workflow solutions, and AI tools reached new performance levels in Q4, significantly enhancing the efficiency for doctors and contributing to superior patient care.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Doximity Inc (DOCS, Financial) is $71.53 with a high estimate of $88.00 and a low estimate of $55.00. The average target implies an upside of 22.31% from the current price of $58.48. More detailed estimate data can be found on the Doximity Inc (DOCS) Forecast page.
Based on the consensus recommendation from 20 brokerage firms, Doximity Inc's (DOCS, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Doximity Inc (DOCS, Financial) in one year is $55.40, suggesting a downside of 5.27% from the current price of $58.48. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Doximity Inc (DOCS) Summary page.
